Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

被引:19
作者
Brown, Jennifer R. [1 ,2 ,3 ]
Walker, Sarah R. [1 ,2 ,3 ]
Heppler, Lisa N. [1 ]
Tyekucheva, Svitlana [4 ]
Nelson, Erik A. [1 ,2 ,3 ]
Klitgaard, Josephine [1 ]
Nicolais, Maria [1 ]
Kroll, Yasmin [1 ]
Xiang, Michael [1 ]
Yeh, Jennifer E. [1 ]
Chaudhury, Mousumi [1 ]
Giaccone, Zachary T. [1 ]
Fernandes, Stacey M. [1 ]
Jacobsen, Eric D. [1 ,2 ,3 ]
Fisher, David C. [1 ,2 ,3 ]
Freedman, Arnold S. [1 ,2 ,3 ]
Davids, Matthew S. [1 ,2 ,3 ]
Supko, Jeffrey G. [5 ]
Wu, Catherine [1 ,2 ,3 ]
Frank, David A. [1 ,2 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Mayer 522B, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
[5] Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA
关键词
TRANSCRIPTION;
D O I
10.1002/ajh.26084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E95 / E98
页数:4
相关论文
共 50 条
  • [21] Discovery of a New STAT3 Inhibitor Acting on the Linker Domain
    Koseki, Tatsuya
    Suehiro, Naoya
    Masuda, Yoshiaki
    Miyoshi, Nao
    Muraoka, Daisuke
    Ogo, Naohisa
    Asai, Akira
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (05) : 792 - 800
  • [22] STAT3 differential scanning fluorimetry and differential scanning light scattering assays: Addressing a missing link in the characterization of STAT3 inhibitor interactions
    Desroses, Matthieu
    Busker, Sander
    Astorga-Wells, Juan
    Attarha, Sanaz
    Kolosenko, Iryna
    Zubarev, Roman A.
    Helleday, Thomas
    Grander, Dan
    Page, Brent D. G.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 160 : 80 - 88
  • [23] Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells
    Rozovski, Uri
    Harris, David M.
    Li, Ping
    Liu, Zhiming
    Jain, Preetesh
    Veletic, Ivo
    Ferrajoli, Alessandra
    Burger, Jan
    Thompson, Philip
    Jain, Nitin
    Wierda, William
    Keating, Michael J.
    Estrov, Zeev
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) : 2076 - 2081
  • [24] In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment
    Severin, Filippo
    Frezzato, Federica
    Visentin, Andrea
    Martini, Veronica
    Trimarco, Valentina
    Carraro, Samuela
    Tibaldi, Elena
    Brunati, Anna Maria
    Piazza, Francesco
    Semenzato, Gianpietro
    Facco, Monica
    Trentin, Livio
    CANCERS, 2019, 11 (12)
  • [25] Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides
    Shiah, Jamie, V
    Grandis, Jennifer R.
    Johnson, Daniel E.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (02) : 219 - 228
  • [26] A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3)
    Liu, Ting
    Qin, Ai-Ping
    Liao, Bin
    Shao, Hui-Ge
    Guo, Li-Juan
    Xie, Gen-Qing
    Yang, Li
    Jiang, Tie-Jian
    BONE, 2014, 67 : 156 - 165
  • [27] Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells
    Rozovski, Uri
    Wu, Ji Yuan
    Harris, David M.
    Liu, Zhiming
    Li, Ping
    Hazan-Halevy, Inbal
    Ferrajoli, Alessandra
    Burger, Jan A.
    O'Brien, Susan
    Jain, Nitin
    Verstovsek, Srdan
    Wierda, William G.
    Keating, Michael J.
    Estrov, Zeev
    BLOOD, 2014, 123 (24) : 3797 - 3802
  • [28] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Johnson, Daniel E.
    O'Keefe, Rachel A.
    Grandis, Jennifer R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (04) : 234 - 248
  • [29] Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
    Siveen, Kodappully Sivaraman
    Sikka, Sakshi
    Surana, Rohit
    Dai, Xiaoyun
    Zhang, Jingwen
    Kumar, Alan Prem
    Tan, Benny K. H.
    Sethi, Gautam
    Bishayee, Anupam
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02): : 136 - 154
  • [30] Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
    Su, Jung-Chen
    Chang, Chuan-Hsun
    Wu, Szu-Hsien
    Shiau, Chung-Wai
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 1248 - 1255